Loading
 Manabu Katano

Manabu Katano

พืชไร่,
Faculty of Agriculture,
Khon Kaen University
8602747600: H-INDEX 4

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells. Morisaki, T
Matsunaga, H
Beppu, K
Ihara, E
Hirano, K
Kanaide, H
Mori, M
Katano, M
0
2. Construction of a transplantable tissue-engineered artificial peritoneum. Kuga, H
Morisaki, T
Nakamura, K
Onishi, H
Matsuda, T
Sueishi, K
Tanaka, M
Katano, M
0
3. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue. Beppu, K
Uchiyama, A
Morisaki, T
Nakamura, K
Noshiro, H
Matsumoto, K
Nakamura, T
Tanaka, M
Katano, M
0
4. Hepatocyte growth factor production by peripheral blood mononuclear cells of recurrent cancer patients. Beppu, K
Uchiyama, A
Morisaki, T
Matsumoto, K
Nakamura, T
Tanaka, M
Katano, M
0
5. The past, the present and future of the OK-432 therapy for patients with malignant effusions. Katano, M
Morisaki, T
0
6. [Autoanalysis of serum immunoproteins (1)]. Katano, M
Shimoyama, Y
Hamano, T
Motegi, H
1974
7. Value of prophylactic oophorectomy in advanced breast cancer with parasternal lymph nodes metastasis. Jimi, M
Katano, M
Kishikawa, H
1977
8. A case of "exulceratio simplex" (Dieulafoy). Katano, M
Fujii, Y
Muto, Y
Watanabe, H
1980
9. Immunogenetic studies of familial large bowel cancer. Katano, M
Fujiwara, H
Toyoda, K
Torisu, M
1980
10. Chemotaxis of Kupffer cells isolated from rodent liver. Katano, M
Miyazaki, K
Aso, M
Torisu, M
1981
11. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)]. Katano, M 1981
12. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)]. Katano, M 1981
13. Neutrophil-mediated tumor cell destruction in cancer ascites. Katano, M
Torisu, M
1982
14. Human monoclonal antibody to a neuroectodermal tumor antigen (OFA-I-2). Katano, M
Sidell, N
Irie, RF
1983
15. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction. Katano, M
Torisu, M
1983
16. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival. Torisu, M
Katano, M
Kimura, Y
Itoh, H
Takesue, M
1983
17. Establishment of an ascitic human melanoma cell line that metastasizes to lung and liver in nude mice. Katano, M
Saxton, RE
Cochran, AJ
Irie, RF
1984
18. Human monoclonal antibody to ganglioside GD2-inhibited human melanoma xenograft. Katano, M
Jien, M
Irie, RF
1984
19. Human monoclonal antibody to tumor-associated ganglioside GD2. Katano, M
Saxton, RE
Irie, RF
1984
20. Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice. Katano, M
Irie, RF
1984
21. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft. Katano, M
Saxton, RE
Tsuchida, T
Irie, RF
1986
22. [Management of malignant ascites with a streptococcal preparation, OK-432: induction of growth inhibition factor(s) against tumor cells]. Katano, M
Yamamoto, H
Hisatsugu, T
1986
23. Radioimmunodetection of human melanoma tumor xenografts with human monoclonal antibodies. Gomibuchi, M
Saxton, RE
Lake, RR
Katano, M
Irie, RF
1986
24. [Tumor growth inhibitory factor (S) produced by lymphocytes in cancer patients with long-term OK-432 therapy]. Katano, M 1986
25. [A case of gastric cancer with multiple liver metastases responding to combination therapy of recombinant interferon-gamma (KW-2202) and 5-FU]. Katano, M
Yamamoto, H
Sato, S
Kitajima, Y
Uchida, Y
Hisatsugu, T
1987
26. [A suppressive effect of PSK, a protein-bound polysaccharide preparation, on tumor growth: a new effect of PSK on cell motility]. Katano, M
Yamamoto, H
Torisu, M
1987
27. [Intratumor injection of OK-432-stimulated peripheral blood mononuclear cells: a significance of mononuclear cell-producing tumor inhibitory factor induced by OK-432]. Mizoguchi, T
Katano, M
Yamamoto, H
Hisatsugu, T
1987
28. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume]. Katano, M
Mizoguchi, T
Yamamoto, H
Hisatsugu, T
Torisu, M
1987
29. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes]. Katano, M
Yamamoto, H
Mizoguchi, T
Hidaka, K
Hisatsugu, T
Torisu, M
1987
30. [Tumor growth inhibition by water-soluble substance from Panax ginseng]. Katano, M
Yamamoto, H
Hisatsugu, T
1987
31. [A tumor inhibitory substance from panax ginseng]. Katano, M
Matsunaga, H
Yamamoto, H
1988
32. [Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice]. Hidaka, K
Yamamoto, H
Harada, S
Katano, M
Fujiwara, H
Mizoguchi, T
Hisatsugu, T
Yamaoka, K
Kisu, T
1988
33. Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation. Katano, M
Yamamoto, H
Mizoguchi, T
Hisatsugu, T
1988
34. Determination of panaxytriol, a new type of tumour growth inhibitor from Panax ginseng, by capillary gas chromatography. Matsunaga, H
Katano, M
Yamamoto, H
Mori, M
Takata, K
Nishi, M
1989
35. Studies on the panaxytriol of Panax ginseng C. A. Meyer. Isolation, determination and antitumor activity. Matsunaga, H
Katano, M
Yamamoto, H
Mori, M
Takata, K
1989
36. [Cell growth inhibitory substance isolated from Panax ginseng root: panaxytriol]. Katano, M
Yamamoto, H
Matsunaga, H
Mori, M
Takata, K
Nakamura, M
1990
37. Cytotoxic activity of polyacetylene compounds in Panax ginseng C. A. Meyer. Matsunaga, H
Katano, M
Yamamoto, H
Fujito, H
Mori, M
Takata, K
1990
38. Inhibitory effect of cis-dehydromatricaria ester isolated from Solidago altissima on the growth of mammalian cells. Matsunaga, H
Katano, M
Tasaki, M
Yamamoto, H
Mori, M
Takata, K
1990
39. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Torisu, M
Hayashi, Y
Ishimitsu, T
Fujimura, T
Iwasaki, K
Katano, M
Yamamoto, H
Kimura, Y
Takesue, M
Kondo, M
1990
40. Synergistic effects of TGIF and interferon gamma (IFN-gamma) on tumor cell growth. TGIF and IFN-gamma. Katano, M
Yamamoto, H
Nakamura, M
Matsuo, T
Hisatsugu, T
1990
41. The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF). Katano, M
Mizoguchi, T
Yamamoto, H
Nakamura, M
Matsuo, T
Hisatugu, T
Kisu, T
Yamaoka, K
Tokunaga, O
1990
42. A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy. Katano, M
Kubota, E
Yamamoto, H
Nakamura, M
Matsuo, T
Hisatsugu, T
Katsuki, T
Koga, H
Ikezaki, K
Tabuchi, K
1991
43. [Eighteen-year experience of cancer immunotherapies--evaluation of their therapeutic benefits and future]. Torisu, M
Uchiyama, A
Goya, T
Iwasaki, K
Katano, M
Yamamoto, H
Kimura, Y
1991
44. [Trans-arterial infusion chemotherapy through the inferior epigastric artery for malignant abdominal tumors without laparotomy]. Mashima, H
Katano, M
Hidaka, K
Yamamoto, H
Hisatsugu, T
Kudo, S
Fukabori, T
Kuroiwa, T
Kishikawa, T
1991
45. [Enhancement effect of fat emulsion for intravenous use (intralipos) on the growth of a human breast cancer cell line in culture: preliminary report]. Katano, M
Iyama, A
Yamamoto, H
Hisatsugu, T
1992
46. [Intra-arterial chemotherapy with granulocyte colony-stimulating factor for breast cancer before surgical treatment]. Mashima, H
Katano, M
Iyama, A
Hamamoto, T
Imoto, A
Sasatomi, E
Hidaka, K
Yamamoto, H
Hisatsugu, T
1992
47. [Strategy for therapy of malignant ascites using MTT assay]. Katano, M
Oogushi, K
Morita, H
Sunaga, T
Matsunaga, H
Yamamoto, H
Hisatsugu, T
1992
48. [Tumor growth inhibition by tumor-infiltrating B cells: preliminary report]. Katano, M
Nagumo, F
Kubota, E
Iyama, A
Yamamoto, H
Hisatsugu, T
Tadano, J
1992
49. Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): activation by autologous tumour cell alone. Katano, M
Nagumo, F
Kubota, E
Yamamoto, H
Matsuo, T
Hisatsugu, T
Tadano, J
1993
50. [Causes of anomalous patterns of haptoglobin using polyacrylamide gel electrophoresis]. Okazaki, T
Kiyokawa, K
Arakawa, H
Kadohno, N
Katano, M
Kanno, T
1993
51. [Clinical study on the effect of continuous transarterial infusion chemotherapy of CDDP for metastatic liver tumors]. Mori, M
Hidaka, K
Mashima, H
Katano, M
Kishikawa, T
Hisatsugu, T
1993
52. HLA-DP class II antigens in transfusion-associated graft versus host disease. Nagumo, F
Sano, M
Tadano, J
Katano, M
Kubota, E
Kikuchi, M
Nose, Y
1993
53. Locoregional immunotherapy of head and neck cancers utilizing allogeneic spleen cells--a report of 2 cases. Kubota, E
Katano, M
Imamura, H
Kurokawa, H
Katsuki, T
Yamamoto, H
Hisatsugu, T
Nagumo, F
Tadano, J
1993
54. Percutaneous pneumatic balloon dilation of the obstructed pancreaticojejunal anastomosis in the management of a case of intractable pancreatic cutaneous fistula. Satoh, H
Hirohashi, Y
Katano, M
Yamamoto, H
Hisatsugu, T
1993
55. The first specific antibody against cytotoxic polyacetylenic alcohol, panaxynol. Saita, T
Katano, M
Matsunaga, H
Yamamoto, H
Fujito, H
Mori, M
1993
56. The possible use of spleen cells for the adoptive immunotherapy of cancer patients. Katano, M
Yamamoto, H
Kubota, E
Nakamura, M
Matsuo, T
Nagumo, F
Hisatsugu, T
Katsuki, T
Tadano, J
1993
57. Tumoricidal effect of human PBMC following stimulation with OK-432 and its application for locoregional immunotherapy in head and neck cancer patients. Kubota, E
Katano, M
Kurokawa, H
Imamura, H
Katsuki, T
Yamamoto, H
Hisatsugu, T
Nagumo, F
Tadano, J
1993
58. A highly sensitive enzyme-linked immunosorbent assay (ELISA) for antitumor polyacetylenic alcohol, panaxytriol. Saita, T
Matsunaga, H
Yamamoto, H
Nagumo, F
Fujito, H
Mori, M
Katano, M
1994
59. Effective induction of human NK cells with OK-432 and further augmentation of their cytolytic function by rIL-2. Hu, ZL
Kubota, E
Imamura, H
Katano, M
Katsuki, T
1994
60. [Establishment and characterization of a new cell line (KT-COLO-8) derived from a colonic mucinous adenocarcinoma]. Kitsuki, H
Morisaki, T
Katano, M
Torisu, M
1994
61. Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2. Katano, M
Matsuo, T
Morisaki, T
Naito, K
Nagumo, F
Kubota, E
Nakamura, M
Hisatsugu, T
Tadano, J
1994
62. Inhibition of tumor cell growth by a human B-cell line. Katano, M
Kubota, E
Nagumo, F
Matsuo, T
Hisatsugu, T
Tadano, J
1994
63. Interleukin-2 (IL-2) production by human B-cell line. Katano, M
Morisaki, T
Matsuo, T
Nakamura, M
Kubota, E
Hisatsugu, T
1994
64. Potentiation of cytotoxicity of mitomycin C by a polyacetylenic alcohol, panaxytriol. Matsunaga, H
Katano, M
Saita, T
Yamamoto, H
Mori, M
1994
65. [Relationship between antiproliferative activity of acetylenic alcohol, panaxydol, and its affinity for target cell membrane]. Matsunaga, H
Saita, T
Nagumo, F
Mori, M
Katano, M
1994
66. A possible mechanism for the cytotoxicity of a polyacetylenic alcohol, panaxytriol: inhibition of mitochondrial respiration. Matsunaga, H
Saita, T
Nagumo, F
Mori, M
Katano, M
1995
67. A possible role of TGF-beta in the formation of malignant effusions. Ikubo, A
Morisaki, T
Katano, M
Kitsuki, H
Anan, K
Uchiyama, A
Tanaka, M
Torisu, M
1995
68. CEA-mediated homotypic aggregation of human colorectal carcinoma cells in a malignant effusion. Kitsuki, H
Katano, M
Morisaki, T
Torisu, M
1995
69. Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis. Katano, M
Nakamura, M
Matsuo, T
Iyama, A
Hisatsugu, T
1995
70. [Low-dose FP (5-FU+low-dose CDDP) therapy for far advanced upper gastro-intestinal carcinoma]. Nakamura, M
Katano, M
Yunotani, S
Hisatsugu, T
Sasadomi, E
Masumoto, H
1995
71. Screening of polyacetylenic alcohols in crude drugs using the ELISA for panaxytriol. Saita, T
Katano, M
Matsunaga, H
Kouno, I
Fujito, H
Mori, M
1995
72. Immunosuppressive cytokines (IL-10, TGF-beta) genes expression in human gastric carcinoma tissues. Morisaki, T
Katano, M
Ikubo, A
Anan, K
Nakamura, M
Nakamura, K
Sato, H
Tanaka, M
Torisu, M
1996
73. Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-gamma in enhancement of surface expression of ICAM-1 on tumor cells in vivo. Kitsuki, H
Katano, M
Ikubo, A
Morisaki, T
Anann, K
Tanaka, M
Torisu, M
1996
74. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Anan, K
Morisaki, T
Katano, M
Ikubo, A
Kitsuki, H
Uchiyama, A
Kuroki, S
Tanaka, M
Torisu, M
1996
75. A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens. Nakamura, M
Katano, M
Fujimoto, K
Morisaki, T
1997
76. [A study of the association between HLA phenotype and serum concentration of soluble HLA class I]. Matsuura, H
Jimbo, S
Miyamura, M
Katano, M
Togashi, K
Matsuda, J
1997
77. Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: correlation with stage of disease. Katano, M
Nakamura, M
Morisaki, T
Fujimoto, K
1997
78. Preoperative assessment of tumor angiogenesis by vascular endothelial growth factor mRNA expression in homogenate samples of breast carcinoma: fine-needle aspirates vs. resection samples. Anan, K
Morisaki, T
Katano, M
Ikubo, A
Tsukahara, Y
Uchiyama, A
Kuroki, S
Tanaka, M
Torisu, M
1997
79. Structures and antiproliferative activity of saponins from Sechium pittieri and S. talamancense. Castro, VH
Ramirez, E
Mora, GA
Iwase, Y
Nagao, T
Okabe, H
Matsunaga, H
Katano, M
Mori, M
1997
80. Antiproliferative constituents in umbelliferae plants. III. Constituents in the root and the ground part of Anthriscus sylvestris Hoffm. Ikeda, R
Nagao, T
Okabe, H
Nakano, Y
Matsunaga, H
Katano, M
Mori, M
1998
81. Antiproliferative constituents in Umbelliferae plants II. Screening for polyacetylenes in some Umbelliferae plants, and isolation of panaxynol and falcarindiol from the root of Heracleum moellendorffii. Nakano, Y
Matsunaga, H
Saita, T
Mori, M
Katano, M
Okabe, H
1998
82. Antiproliferative constituents in umbelliferae plants. IV. Constituents in the fruits of Anthriscus sylvestris Hoffm. Ikeda, R
Nagao, T
Okabe, H
Nakano, Y
Matsunaga, H
Katano, M
Mori, M
1998
83. Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential. Anan, K
Morisaki, T
Katano, M
Ikubo, A
Tsukahara, Y
Kojima, M
Uchiyama, A
Kuroki, S
Torisu, M
Tanaka, M
1998
84. Expression of interleukin (IL)-12 mRNA in gastric carcinoma specimens: cellular antitumor immune responses. Katano, M
Nakamura, M
Kuwahara, A
Fujimoto, K
Matsunaga, H
Miyazaki, K
Morisaki, T
1998
85. Novel antiproliferative falcarindiol furanocoumarin ethers from the root of Angelica japonica. Furumi, K
Fujioka, T
Fujii, H
Okabe, H
Nakano, Y
Matsunaga, H
Katano, M
Mori, M
Mihashi, K
1998
86. Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma. Katano, M
Nakamura, M
Fujimoto, K
Miyazaki, K
Morisaki, T
1998
87. Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma. Nakamura, M
Katano, M
Kuwahara, A
Fujimoto, K
Miyazaki, K
Morisaki, T
Mori, M
1998
88. Antiproliferative constituents from umbelliferae plants. V. A new furanocoumarin and falcarindiol furanocoumarin ethers from the root of Angelica japonica. Fujioka, T
Furumi, K
Fujii, H
Okabe, H
Mihashi, K
Nakano, Y
Matsunaga, H
Katano, M
Mori, M
1999
89. Comparison of rice yield after various years of cultivation by natural farming Katano, M. 1999
90. New therapeutic strategy for gastric carcinoma: a two-step evaluation of malignant potential from its molecular biologic and pathologic characteristics. Kuwahara, A
Katano, M
Nakamura, M
Fujimoto, K
Miyazaki, K
Mori, M
Morisaki, T
1999
91. Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential. Sato, N
Mizumoto, K
Beppu, K
Maehara, N
Kusumoto, M
Nabae, T
Morisaki, T
Katano, M
Tanaka, M
2000
92. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Kojima, M
Morisaki, T
Izuhara, K
Uchiyama, A
Matsunari, Y
Katano, M
Tanaka, M
2000
93. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs. Zhang, H
Morisaki, T
Matsunaga, H
Sato, N
Uchiyama, A
Hashizume, K
Nagumo, F
Tadano, J
Katano, M
2000
94. Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas. Kojima, M
Morisaki, T
Uchiyama, A
Doi, F
Mibu, R
Katano, M
Tanaka, M
2001
95. Expression of melanoma antigen-encoding gene-1 predicts lymph node involvement in early gastric carcinomas. Kuwahara, A
Katano, M
Nakamura, M
Morisaki, T
Miyazaki, K
Fujimoto, K
2001
96. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Sasaki, N
Morisaki, T
Hashizume, K
Yao, T
Tsuneyoshi, M
Noshiro, H
Nakamura, K
Yamanaka, T
Uchiyama, A
Tanaka, M
Katano, M
2001
97. Simulated microgravity culture system for a 3-D carcinoma tissue model. K Nakamura
H Kuga
T Morisaki
E Baba
N Sato
K Mizumoto
K Sueishi
M Tanaka
M Katano
2002
98. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4 M Saimura
E Nagai
K Mizumoto
N Maehara
YA Minamishima
M Katano
K Matsumoto
T Nakamura
M Tanaka
2002
99. Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer M Kubo
T Morisaki
H Kuroki
A Tasaki
N Yamanaka
K Matsumoto
K Nakamura
H Onishi
E Baba
M Katano
2003
100. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model H Kuga
T Morisaki
K Nakamura
H Onishi
H Noshiro
A Uchiyama
M Tanaka
M Katano
2003
101. Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer T Morisaki
M Katano
2003
102. Genome wide analysis of TNF-inducible genes reveals that antioxidant enzymes are induced by TNF and responsible for elimination of ROS T Sasazuki
T Okazaki
K Tada
S Sakon-Komazawa
M Katano
M Tanaka
H Yagita
K Okumura
N Tominaga
Y Hayashizaki
Y Okazaki
H Nakano
2004
103. Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappa B autocrine loop H Onishi
H Kuroki
K Matsumoto
E Baba
N Sasaki
H Kuga
M Tanaka
M Katano
T Morisaki
2004
104. Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells A Tasaki
N Yamanaka
M Kubo
K Matsumoto
H Kuroki
K Nakamura
C Nakahara
H Onishi
H Kuga
E Baba
M Tanaka
T Morisaki
M Katano
2004
105. Influence of three-dimensional culture in a type II collagen sponge on primary cultured and dedifferentiated chondrocytes T Mukaida
K Urabe
K Naruse
J Aikawa
M Katano
SH Hyon
M Itoman
2005
106. Myofibroblasts correlate with lymphatic microvessel density and lymph node metastasis in early-stage invasive colorectal carcinoma P Liang
JW Hong
H Ubukata
G Liu
M Katano
G Motohashi
T Kasuga
Y Watanabe
I Nakada
T Tabuchi
2005
107. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation. Akiyoshi, T
Nakamura, M
Koga, K
Nakashima, H
Yao, T
Tsuneyoshi, M
Tanaka, M
Katano, M
2006
108. Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ER alpha-positive gastric cancer Kameda, C
Nakamura, M
Tanaka, H
Yamasaki, A
Kubo, M
Tanaka, M
Onishi, H
Katano, M
2010
109. Y-BOX BINDING PROTEIN-1 IS INVOLVED IN TUMOR ANGIOGENESIS AND A PROMISING THERAPEUTIC TARGET K. Shinkai
K. Nakano
H. Onishi
M. Tanaka
M. Katano
2014
Count 1 98 12 0

Title Authors Year Publication name Cited count
< 2017 2018 2019 2020 2021 2022 Total
1. Comparison of rice yield after various years of cultivation by natural farming Katano, M. 1999 Plant Production Science
1 (2), pp. 58-64

Title Authors Year Journal title
1. [Autoanalysis of serum immunoproteins (1)]. Katano, M
Shimoyama, Y
Hamano, T
Motegi, H
1974 Rinsho byori. The Japanese journal of clinical pathology
10 (22), pp. 254
2. Value of prophylactic oophorectomy in advanced breast cancer with parasternal lymph nodes metastasis. Jimi, M
Katano, M
Kishikawa, H
1977 The Japanese journal of surgery
2 (7), pp. 49-53
3. A case of "exulceratio simplex" (Dieulafoy). Katano, M
Fujii, Y
Muto, Y
Watanabe, H
1980 The Japanese journal of surgery
1 (10), pp. 63-6
4. Immunogenetic studies of familial large bowel cancer. Katano, M
Fujiwara, H
Toyoda, K
Torisu, M
1980 Gan
5 (71), pp. 583-8
5. Chemotaxis of Kupffer cells isolated from rodent liver. Katano, M
Miyazaki, K
Aso, M
Torisu, M
1981 Microbiology and immunology
10 (25), pp. 1059-66
6. [Treatment of malignant ascites. II. Immunological studies on disappearance of ascites by intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)]. Katano, M 1981 Fukuoka igaku zasshi = Hukuoka acta medica
10 (72), pp. 543-55
7. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)]. Katano, M 1981 Fukuoka igaku zasshi = Hukuoka acta medica
10 (72), pp. 532-42
8. Neutrophil-mediated tumor cell destruction in cancer ascites. Katano, M
Torisu, M
1982 Cancer
1 (50), pp. 62-8
9. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction. Katano, M
Torisu, M
1983 Surgery
3 (93), pp. 365-73
10. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival. Torisu, M
Katano, M
Kimura, Y
Itoh, H
Takesue, M
1983 Surgery
3 (93), pp. 357-64
11. Human monoclonal antibody to a neuroectodermal tumor antigen (OFA-I-2). Katano, M
Sidell, N
Irie, RF
1983 Annals of the New York Academy of Sciences
(417), pp. 427-34
12. Human monoclonal antibody to ganglioside GD2-inhibited human melanoma xenograft. Katano, M
Jien, M
Irie, RF
1984 European journal of cancer & clinical oncology
8 (20), pp. 1053-9
13. Human monoclonal antibody to tumor-associated ganglioside GD2. Katano, M
Saxton, RE
Irie, RF
1984 Journal of clinical & laboratory immunology
3 (15), pp. 119-26
14. Establishment of an ascitic human melanoma cell line that metastasizes to lung and liver in nude mice. Katano, M
Saxton, RE
Cochran, AJ
Irie, RF
1984 Journal of cancer research and clinical oncology
2 (108), pp. 197-203
15. Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice. Katano, M
Irie, RF
1984 Immunology letters
4 (8), pp. 169-74
16. Radioimmunodetection of human melanoma tumor xenografts with human monoclonal antibodies. Gomibuchi, M
Saxton, RE
Lake, RR
Katano, M
Irie, RF
1986 International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology
1 (13), pp. 13-9
17. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft. Katano, M
Saxton, RE
Tsuchida, T
Irie, RF
1986 Japanese journal of cancer research : Gann
6 (77), pp. 584-94
18. [Tumor growth inhibitory factor (S) produced by lymphocytes in cancer patients with long-term OK-432 therapy]. Katano, M 1986 Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
9 (83), pp. 2088
19. [Management of malignant ascites with a streptococcal preparation, OK-432: induction of growth inhibition factor(s) against tumor cells]. Katano, M
Yamamoto, H
Hisatsugu, T
1986 Nihon Geka Gakkai zasshi
4 (87), pp. 471
20. [A case of gastric cancer with multiple liver metastases responding to combination therapy of recombinant interferon-gamma (KW-2202) and 5-FU]. Katano, M
Yamamoto, H
Sato, S
Kitajima, Y
Uchida, Y
Hisatsugu, T
1987 Gan to kagaku ryoho. Cancer & chemotherapy
12 (14), pp. 3351-4
21. [A suppressive effect of PSK, a protein-bound polysaccharide preparation, on tumor growth: a new effect of PSK on cell motility]. Katano, M
Yamamoto, H
Torisu, M
1987 Gan to kagaku ryoho. Cancer & chemotherapy
7 (14), pp. 2321-6
22. [Intratumor injection of OK-432-stimulated peripheral blood mononuclear cells: a significance of mononuclear cell-producing tumor inhibitory factor induced by OK-432]. Mizoguchi, T
Katano, M
Yamamoto, H
Hisatsugu, T
1987 Nihon Geka Gakkai zasshi
6 (88), pp. 794
23. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume]. Katano, M
Mizoguchi, T
Yamamoto, H
Hisatsugu, T
Torisu, M
1987 Nihon Geka Gakkai zasshi
12 (88), pp. 1676-83
24. [Tumor growth inhibition by water-soluble substance from Panax ginseng]. Katano, M
Yamamoto, H
Hisatsugu, T
1987 Nihon Geka Gakkai zasshi
12 (88), pp. 1754
25. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes]. Katano, M
Yamamoto, H
Mizoguchi, T
Hidaka, K
Hisatsugu, T
Torisu, M
1987 Gan to kagaku ryoho. Cancer & chemotherapy
8 (14), pp. 2464-8
26. [A tumor inhibitory substance from panax ginseng]. Katano, M
Matsunaga, H
Yamamoto, H
1988 Nihon Geka Gakkai zasshi
6 (89), pp. 971
27. Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation. Katano, M
Yamamoto, H
Mizoguchi, T
Hisatsugu, T
1988 Cancer immunology, immunotherapy : CII
3 (27), pp. 198-204
28. [Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice]. Hidaka, K
Yamamoto, H
Harada, S
Katano, M
Fujiwara, H
Mizoguchi, T
Hisatsugu, T
Yamaoka, K
Kisu, T
1988 The Japanese journal of antibiotics
9 (41), pp. 1295-303
29. Determination of panaxytriol, a new type of tumour growth inhibitor from Panax ginseng, by capillary gas chromatography. Matsunaga, H
Katano, M
Yamamoto, H
Mori, M
Takata, K
Nishi, M
1989 Journal of chromatography
(481), pp. 368-72
30. Studies on the panaxytriol of Panax ginseng C. A. Meyer. Isolation, determination and antitumor activity. Matsunaga, H
Katano, M
Yamamoto, H
Mori, M
Takata, K
1989 Chemical & pharmaceutical bulletin
5 (37), pp. 1279-81
31. Cytotoxic activity of polyacetylene compounds in Panax ginseng C. A. Meyer. Matsunaga, H
Katano, M
Yamamoto, H
Fujito, H
Mori, M
Takata, K
1990 Chemical & pharmaceutical bulletin
12 (38), pp. 3480-2
32. The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF). Katano, M
Mizoguchi, T
Yamamoto, H
Nakamura, M
Matsuo, T
Hisatugu, T
Kisu, T
Yamaoka, K
Tokunaga, O
1990 The Japanese journal of surgery
1 (20), pp. 76-82
33. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Torisu, M
Hayashi, Y
Ishimitsu, T
Fujimura, T
Iwasaki, K
Katano, M
Yamamoto, H
Kimura, Y
Takesue, M
Kondo, M
1990 Cancer immunology, immunotherapy : CII
5 (31), pp. 261-8
34. Inhibitory effect of cis-dehydromatricaria ester isolated from Solidago altissima on the growth of mammalian cells. Matsunaga, H
Katano, M
Tasaki, M
Yamamoto, H
Mori, M
Takata, K
1990 Chemical & pharmaceutical bulletin
12 (38), pp. 3483-4
35. Synergistic effects of TGIF and interferon gamma (IFN-gamma) on tumor cell growth. TGIF and IFN-gamma. Katano, M
Yamamoto, H
Nakamura, M
Matsuo, T
Hisatsugu, T
1990 Biotherapy (Dordrecht, Netherlands)
1 (2), pp. 33-40
36. [Cell growth inhibitory substance isolated from Panax ginseng root: panaxytriol]. Katano, M
Yamamoto, H
Matsunaga, H
Mori, M
Takata, K
Nakamura, M
1990 Gan to kagaku ryoho. Cancer & chemotherapy
5 (17), pp. 1045-9
37. [Trans-arterial infusion chemotherapy through the inferior epigastric artery for malignant abdominal tumors without laparotomy]. Mashima, H
Katano, M
Hidaka, K
Yamamoto, H
Hisatsugu, T
Kudo, S
Fukabori, T
Kuroiwa, T
Kishikawa, T
1991 Gan to kagaku ryoho. Cancer & chemotherapy
11 (18), pp. 1864-8
38. [Eighteen-year experience of cancer immunotherapies--evaluation of their therapeutic benefits and future]. Torisu, M
Uchiyama, A
Goya, T
Iwasaki, K
Katano, M
Yamamoto, H
Kimura, Y
1991 Nihon Geka Gakkai zasshi
9 (92), pp. 1212-6
39. A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy. Katano, M
Kubota, E
Yamamoto, H
Nakamura, M
Matsuo, T
Hisatsugu, T
Katsuki, T
Koga, H
Ikezaki, K
Tabuchi, K
1991 Biotherapy (Dordrecht, Netherlands)
4 (3), pp. 373-9
40. [Strategy for therapy of malignant ascites using MTT assay]. Katano, M
Oogushi, K
Morita, H
Sunaga, T
Matsunaga, H
Yamamoto, H
Hisatsugu, T
1992 Gan to kagaku ryoho. Cancer & chemotherapy
6 (19), pp. 811-5
41. [Intra-arterial chemotherapy with granulocyte colony-stimulating factor for breast cancer before surgical treatment]. Mashima, H
Katano, M
Iyama, A
Hamamoto, T
Imoto, A
Sasatomi, E
Hidaka, K
Yamamoto, H
Hisatsugu, T
1992 Gan to kagaku ryoho. Cancer & chemotherapy
10 (19), pp. 1609-12
42. [Tumor growth inhibition by tumor-infiltrating B cells: preliminary report]. Katano, M
Nagumo, F
Kubota, E
Iyama, A
Yamamoto, H
Hisatsugu, T
Tadano, J
1992 Nihon Geka Gakkai zasshi
7 (93), pp. 772
43. [Enhancement effect of fat emulsion for intravenous use (intralipos) on the growth of a human breast cancer cell line in culture: preliminary report]. Katano, M
Iyama, A
Yamamoto, H
Hisatsugu, T
1992 Nihon Geka Gakkai zasshi
8 (93), pp. 865
44. HLA-DP class II antigens in transfusion-associated graft versus host disease. Nagumo, F
Sano, M
Tadano, J
Katano, M
Kubota, E
Kikuchi, M
Nose, Y
1993 Lancet (London, England)
8884 (342), pp. 1424
45. Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): activation by autologous tumour cell alone. Katano, M
Nagumo, F
Kubota, E
Yamamoto, H
Matsuo, T
Hisatsugu, T
Tadano, J
1993 Biotherapy (Dordrecht, Netherlands)
1 (6), pp. 25-32
46. Percutaneous pneumatic balloon dilation of the obstructed pancreaticojejunal anastomosis in the management of a case of intractable pancreatic cutaneous fistula. Satoh, H
Hirohashi, Y
Katano, M
Yamamoto, H
Hisatsugu, T
1993 Gastroenterologia Japonica
2 (28), pp. 317-21
47. Locoregional immunotherapy of head and neck cancers utilizing allogeneic spleen cells--a report of 2 cases. Kubota, E
Katano, M
Imamura, H
Kurokawa, H
Katsuki, T
Yamamoto, H
Hisatsugu, T
Nagumo, F
Tadano, J
1993 Biotherapy (Dordrecht, Netherlands)
3 (6), pp. 175-82
48. [Clinical study on the effect of continuous transarterial infusion chemotherapy of CDDP for metastatic liver tumors]. Mori, M
Hidaka, K
Mashima, H
Katano, M
Kishikawa, T
Hisatsugu, T
1993 Gan to kagaku ryoho. Cancer & chemotherapy
11 (20), pp. 1547-50
49. The first specific antibody against cytotoxic polyacetylenic alcohol, panaxynol. Saita, T
Katano, M
Matsunaga, H
Yamamoto, H
Fujito, H
Mori, M
1993 Chemical & pharmaceutical bulletin
3 (41), pp. 549-52
50. [Causes of anomalous patterns of haptoglobin using polyacrylamide gel electrophoresis]. Okazaki, T
Kiyokawa, K
Arakawa, H
Kadohno, N
Katano, M
Kanno, T
1993 Rinsho byori. The Japanese journal of clinical pathology
3 (41), pp. 298-302
51. The possible use of spleen cells for the adoptive immunotherapy of cancer patients. Katano, M
Yamamoto, H
Kubota, E
Nakamura, M
Matsuo, T
Nagumo, F
Hisatsugu, T
Katsuki, T
Tadano, J
1993 Surgery today
1 (23), pp. 13-20
52. Tumoricidal effect of human PBMC following stimulation with OK-432 and its application for locoregional immunotherapy in head and neck cancer patients. Kubota, E
Katano, M
Kurokawa, H
Imamura, H
Katsuki, T
Yamamoto, H
Hisatsugu, T
Nagumo, F
Tadano, J
1993 Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
1 (21), pp. 30-7
53. Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2. Katano, M
Matsuo, T
Morisaki, T
Naito, K
Nagumo, F
Kubota, E
Nakamura, M
Hisatsugu, T
Tadano, J
1994 Cancer immunology, immunotherapy : CII
3 (39), pp. 161-6
54. [Relationship between antiproliferative activity of acetylenic alcohol, panaxydol, and its affinity for target cell membrane]. Matsunaga, H
Saita, T
Nagumo, F
Mori, M
Katano, M
1994 Gan to kagaku ryoho. Cancer & chemotherapy
15 (21), pp. 2585-9
55. [Establishment and characterization of a new cell line (KT-COLO-8) derived from a colonic mucinous adenocarcinoma]. Kitsuki, H
Morisaki, T
Katano, M
Torisu, M
1994 Human cell
3 (7), pp. 145-50
56. A highly sensitive enzyme-linked immunosorbent assay (ELISA) for antitumor polyacetylenic alcohol, panaxytriol. Saita, T
Matsunaga, H
Yamamoto, H
Nagumo, F
Fujito, H
Mori, M
Katano, M
1994 Biological & pharmaceutical bulletin
6 (17), pp. 798-802
57. Potentiation of cytotoxicity of mitomycin C by a polyacetylenic alcohol, panaxytriol. Matsunaga, H
Katano, M
Saita, T
Yamamoto, H
Mori, M
1994 Cancer chemotherapy and pharmacology
4 (33), pp. 291-7
58. Inhibition of tumor cell growth by a human B-cell line. Katano, M
Kubota, E
Nagumo, F
Matsuo, T
Hisatsugu, T
Tadano, J
1994 Biotherapy (Dordrecht, Netherlands)
1 (8), pp. 1-6
59. Effective induction of human NK cells with OK-432 and further augmentation of their cytolytic function by rIL-2. Hu, ZL
Kubota, E
Imamura, H
Katano, M
Katsuki, T
1994 Microbiology and immunology
3 (38), pp. 183-90
60. Interleukin-2 (IL-2) production by human B-cell line. Katano, M
Morisaki, T
Matsuo, T
Nakamura, M
Kubota, E
Hisatsugu, T
1994 Cellular immunology
2 (159), pp. 262-70
61. A possible role of TGF-beta in the formation of malignant effusions. Ikubo, A
Morisaki, T
Katano, M
Kitsuki, H
Anan, K
Uchiyama, A
Tanaka, M
Torisu, M
1995 Clinical immunology and immunopathology
1 (77), pp. 27-32
62. [Low-dose FP (5-FU+low-dose CDDP) therapy for far advanced upper gastro-intestinal carcinoma]. Nakamura, M
Katano, M
Yunotani, S
Hisatsugu, T
Sasadomi, E
Masumoto, H
1995 Gan to kagaku ryoho. Cancer & chemotherapy
14 (22), pp. 2081-6
63. A possible mechanism for the cytotoxicity of a polyacetylenic alcohol, panaxytriol: inhibition of mitochondrial respiration. Matsunaga, H
Saita, T
Nagumo, F
Mori, M
Katano, M
1995 Cancer chemotherapy and pharmacology
4 (35), pp. 291-6
64. CEA-mediated homotypic aggregation of human colorectal carcinoma cells in a malignant effusion. Kitsuki, H
Katano, M
Morisaki, T
Torisu, M
1995 Cancer letters
1 (88), pp. 7-13
65. Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis. Katano, M
Nakamura, M
Matsuo, T
Iyama, A
Hisatsugu, T
1995 Surgery today
3 (25), pp. 202-6
66. Screening of polyacetylenic alcohols in crude drugs using the ELISA for panaxytriol. Saita, T
Katano, M
Matsunaga, H
Kouno, I
Fujito, H
Mori, M
1995 Biological & pharmaceutical bulletin
7 (18), pp. 933-7
67. Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-gamma in enhancement of surface expression of ICAM-1 on tumor cells in vivo. Kitsuki, H
Katano, M
Ikubo, A
Morisaki, T
Anann, K
Tanaka, M
Torisu, M
1996 Clinical immunology and immunopathology
3 (78), pp. 283-90
68. Immunosuppressive cytokines (IL-10, TGF-beta) genes expression in human gastric carcinoma tissues. Morisaki, T
Katano, M
Ikubo, A
Anan, K
Nakamura, M
Nakamura, K
Sato, H
Tanaka, M
Torisu, M
1996 Journal of surgical oncology
4 (63), pp. 234-9
69. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Anan, K
Morisaki, T
Katano, M
Ikubo, A
Kitsuki, H
Uchiyama, A
Kuroki, S
Tanaka, M
Torisu, M
1996 Surgery
3 (119), pp. 333-9
70. A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens. Nakamura, M
Katano, M
Fujimoto, K
Morisaki, T
1997 Annals of surgery
1 (226), pp. 35-42
71. [A study of the association between HLA phenotype and serum concentration of soluble HLA class I]. Matsuura, H
Jimbo, S
Miyamura, M
Katano, M
Togashi, K
Matsuda, J
1997 Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology
2 (20), pp. 102-7
72. Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: correlation with stage of disease. Katano, M
Nakamura, M
Morisaki, T
Fujimoto, K
1997 Journal of surgical oncology
3 (64), pp. 195-201
73. Structures and antiproliferative activity of saponins from Sechium pittieri and S. talamancense. Castro, VH
Ramirez, E
Mora, GA
Iwase, Y
Nagao, T
Okabe, H
Matsunaga, H
Katano, M
Mori, M
1997 Chemical & pharmaceutical bulletin
2 (45), pp. 349-58
74. Preoperative assessment of tumor angiogenesis by vascular endothelial growth factor mRNA expression in homogenate samples of breast carcinoma: fine-needle aspirates vs. resection samples. Anan, K
Morisaki, T
Katano, M
Ikubo, A
Tsukahara, Y
Uchiyama, A
Kuroki, S
Tanaka, M
Torisu, M
1997 Journal of surgical oncology
4 (66), pp. 257-63
75. Transforming growth factor beta1 (TGF-beta1) is a preoperative prognostic indicator in advanced gastric carcinoma. Nakamura, M
Katano, M
Kuwahara, A
Fujimoto, K
Miyazaki, K
Morisaki, T
Mori, M
1998 British journal of cancer
10 (78), pp. 1373-8
76. Expression of interleukin (IL)-12 mRNA in gastric carcinoma specimens: cellular antitumor immune responses. Katano, M
Nakamura, M
Kuwahara, A
Fujimoto, K
Matsunaga, H
Miyazaki, K
Morisaki, T
1998 Journal of surgical oncology
1 (67), pp. 11-7
77. Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma. Katano, M
Nakamura, M
Fujimoto, K
Miyazaki, K
Morisaki, T
1998 Annals of surgery
3 (227), pp. 365-71
78. Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential. Anan, K
Morisaki, T
Katano, M
Ikubo, A
Tsukahara, Y
Kojima, M
Uchiyama, A
Kuroki, S
Torisu, M
Tanaka, M
1998 European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
1 (24), pp. 28-33
79. Novel antiproliferative falcarindiol furanocoumarin ethers from the root of Angelica japonica. Furumi, K
Fujioka, T
Fujii, H
Okabe, H
Nakano, Y
Matsunaga, H
Katano, M
Mori, M
Mihashi, K
1998 Bioorganic & medicinal chemistry letters
1 (8), pp. 93-6
80. Antiproliferative constituents in Umbelliferae plants II. Screening for polyacetylenes in some Umbelliferae plants, and isolation of panaxynol and falcarindiol from the root of Heracleum moellendorffii. Nakano, Y
Matsunaga, H
Saita, T
Mori, M
Katano, M
Okabe, H
1998 Biological & pharmaceutical bulletin
3 (21), pp. 257-61
81. Antiproliferative constituents in umbelliferae plants. III. Constituents in the root and the ground part of Anthriscus sylvestris Hoffm. Ikeda, R
Nagao, T
Okabe, H
Nakano, Y
Matsunaga, H
Katano, M
Mori, M
1998 Chemical & pharmaceutical bulletin
5 (46), pp. 871-4
82. Antiproliferative constituents in umbelliferae plants. IV. Constituents in the fruits of Anthriscus sylvestris Hoffm. Ikeda, R
Nagao, T
Okabe, H
Nakano, Y
Matsunaga, H
Katano, M
Mori, M
1998 Chemical & pharmaceutical bulletin
5 (46), pp. 875-8
83. New therapeutic strategy for gastric carcinoma: a two-step evaluation of malignant potential from its molecular biologic and pathologic characteristics. Kuwahara, A
Katano, M
Nakamura, M
Fujimoto, K
Miyazaki, K
Mori, M
Morisaki, T
1999 Journal of surgical oncology
3 (72), pp. 142-9
84. Antiproliferative constituents from umbelliferae plants. V. A new furanocoumarin and falcarindiol furanocoumarin ethers from the root of Angelica japonica. Fujioka, T
Furumi, K
Fujii, H
Okabe, H
Mihashi, K
Nakano, Y
Matsunaga, H
Katano, M
Mori, M
1999 Chemical & pharmaceutical bulletin
1 (47), pp. 96-100
85. Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-beta1 and MMPs. Zhang, H
Morisaki, T
Matsunaga, H
Sato, N
Uchiyama, A
Hashizume, K
Nagumo, F
Tadano, J
Katano, M
2000 Clinical & experimental metastasis
4 (18), pp. 343-52
86. Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential. Sato, N
Mizumoto, K
Beppu, K
Maehara, N
Kusumoto, M
Nabae, T
Morisaki, T
Katano, M
Tanaka, M
2000 Cancer letters
2 (155), pp. 153-61
87. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Kojima, M
Morisaki, T
Izuhara, K
Uchiyama, A
Matsunari, Y
Katano, M
Tanaka, M
2000 Oncogene
9 (19), pp. 1225-31
88. Expression of melanoma antigen-encoding gene-1 predicts lymph node involvement in early gastric carcinomas. Kuwahara, A
Katano, M
Nakamura, M
Morisaki, T
Miyazaki, K
Fujimoto, K
2001 Digestive diseases and sciences
2 (46), pp. 262-7
89. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Sasaki, N
Morisaki, T
Hashizume, K
Yao, T
Tsuneyoshi, M
Noshiro, H
Nakamura, K
Yamanaka, T
Uchiyama, A
Tanaka, M
Katano, M
2001 Clinical cancer research : an official journal of the American Association for Cancer Research
12 (7), pp. 4136-42
90. Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomas. Kojima, M
Morisaki, T
Uchiyama, A
Doi, F
Mibu, R
Katano, M
Tanaka, M
2001 Annals of surgical oncology
5 (8), pp. 458-65
91. Simulated microgravity culture system for a 3-D carcinoma tissue model. Nakamura, K
Kuga, H
Morisaki, T
Baba, E
Sato, N
Mizumoto, K
Sueishi, K
Tanaka, M
Katano, M
2002 BioTechniques
5 (33), pp. 1068-70, 1072, 1074-6
92. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation. Akiyoshi, T
Nakamura, M
Koga, K
Nakashima, H
Yao, T
Tsuneyoshi, M
Tanaka, M
Katano, M
2006 Gut
7 (55), pp. 991-9
93. Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ERalpha-positive gastric cancer. Kameda, C
Nakamura, M
Tanaka, H
Yamasaki, A
Kubo, M
Tanaka, M
Onishi, H
Katano, M
2010 British journal of cancer
4 (102), pp. 738-47
94. The past, the present and future of the OK-432 therapy for patients with malignant effusions. Katano, M
Morisaki, T
Anticancer research
5 (18), pp. 3917-25
95. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells. Morisaki, T
Matsunaga, H
Beppu, K
Ihara, E
Hirano, K
Kanaide, H
Mori, M
Katano, M
Anticancer research
5 (20), pp. 3363-73
96. Construction of a transplantable tissue-engineered artificial peritoneum. Kuga, H
Morisaki, T
Nakamura, K
Onishi, H
Matsuda, T
Sueishi, K
Tanaka, M
Katano, M
European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes
5 (36), pp. 323-30
97. Hepatocyte growth factor production by peripheral blood mononuclear cells of recurrent cancer patients. Beppu, K
Uchiyama, A
Morisaki, T
Matsumoto, K
Nakamura, T
Tanaka, M
Katano, M
Anticancer research
3 (21), pp. 2195-200
98. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue. Beppu, K
Uchiyama, A
Morisaki, T
Nakamura, K
Noshiro, H
Matsumoto, K
Nakamura, T
Tanaka, M
Katano, M
Anticancer research
2 (20), pp. 1263-7

Title Authors Year Journal title Cited count
< 2017 2018 2019 2020 2021 2022 Total
1. Simulated microgravity culture system for a 3-D carcinoma tissue model K Nakamura
H Kuga
T Morisaki
E Baba
N Sato
K Mizumoto
K Sueishi
M Tanaka
M Katano
2002 BIOTECHNIQUES
5.0 (33.0), pp. 1068.0-+
17 0 0 0 0 0 17
2. Tumor suppression through angiogenesis inhibition by SUIT-2 pancreatic cancer cells genetically engineered to secrete NK4 M Saimura
E Nagai
K Mizumoto
N Maehara
YA Minamishima
M Katano
K Matsumoto
T Nakamura
M Tanaka
2002 CLINICAL CANCER RESEARCH
10.0 (8.0), pp. 3243.0-3249.0
27 0 0 0 0 0 27
3. Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer M Kubo
T Morisaki
H Kuroki
A Tasaki
N Yamanaka
K Matsumoto
K Nakamura
H Onishi
E Baba
M Katano
2003 ANTICANCER RESEARCH
6A (23.0), pp. 4443.0-4449.0
17 0 0 0 0 0 17
4. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model H Kuga
T Morisaki
K Nakamura
H Onishi
H Noshiro
A Uchiyama
M Tanaka
M Katano
2003 ONCOGENE
49.0 (22.0), pp. 7838.0-7847.0
20 0 0 0 0 0 20
5. Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer T Morisaki
M Katano
2003 CURRENT MEDICINAL CHEMISTRY
23.0 (10.0), pp. 2517.0-2521.0
21 0 0 0 0 0 21
6. Genome wide analysis of TNF-inducible genes reveals that antioxidant enzymes are induced by TNF and responsible for elimination of ROS T Sasazuki
T Okazaki
K Tada
S Sakon-Komazawa
M Katano
M Tanaka
H Yagita
K Okumura
N Tominaga
Y Hayashizaki
Y Okazaki
H Nakano
2004 MOLECULAR IMMUNOLOGY
5.0 (41.0), pp. 547.0-551.0
24 0 0 0 0 0 24
7. Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappa B autocrine loop H Onishi
H Kuroki
K Matsumoto
E Baba
N Sasaki
H Kuga
M Tanaka
M Katano
T Morisaki
2004 CANCER IMMUNOLOGY IMMUNOTHERAPY
12.0 (53.0), pp. 1093.0-1100.0
16 0 0 0 0 0 16
8. Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells A Tasaki
N Yamanaka
M Kubo
K Matsumoto
H Kuroki
K Nakamura
C Nakahara
H Onishi
H Kuga
E Baba
M Tanaka
T Morisaki
M Katano
2004 JOURNAL OF IMMUNOLOGICAL METHODS
1-2 (287.0), pp. 79.0-90.0
15 0 0 0 0 0 15
9. Influence of three-dimensional culture in a type II collagen sponge on primary cultured and dedifferentiated chondrocytes T Mukaida
K Urabe
K Naruse
J Aikawa
M Katano
SH Hyon
M Itoman
2005 JOURNAL OF ORTHOPAEDIC SCIENCE
5.0 (10.0), pp. 521.0-528.0
27 0 0 0 0 0 27
10. Myofibroblasts correlate with lymphatic microvessel density and lymph node metastasis in early-stage invasive colorectal carcinoma P Liang
JW Hong
H Ubukata
G Liu
M Katano
G Motohashi
T Kasuga
Y Watanabe
I Nakada
T Tabuchi
2005 ANTICANCER RESEARCH
4.0 (25.0), pp. 2705.0-2712.0
21 0 0 0 0 0 21
11. Oestrogen receptor-alpha contributes to the regulation of the hedgehog signalling pathway in ER alpha-positive gastric cancer C. Kameda
M. Nakamura
H. Tanaka
A. Yamasaki
M. Kubo
M. Tanaka
H. Onishi
M. Katano
2010 BRITISH JOURNAL OF CANCER
4.0 (102.0), pp. 738.0-747.0
22 0 0 0 0 0 22
12. Y-BOX BINDING PROTEIN-1 IS INVOLVED IN TUMOR ANGIOGENESIS AND A PROMISING THERAPEUTIC TARGET K. Shinkai
K. Nakano
H. Onishi
M. Tanaka
M. Katano
2014 ANNALS OF ONCOLOGY
(25.0), pp.
0 0 0 0 0 0 0

Title Authors Year Journal title

Title Authors NRIIS type Year NRIIS Scholarship

0.037889957427978516